Patents by Inventor Dale B. Schenk

Dale B. Schenk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention and treatment of amyloidogenic disease
    Patent number: 6808712
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response an amyloid deposit in the patient. The methods are particularly useful for prophylatic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: October 26, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
    Publication number: 20040175394
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: September 9, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787139
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787144
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787143
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787138
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787523
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6787140
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • N-Terminal amyloid-&bgr; antibodies
    Patent number: 6787637
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 7, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Humanized antibodies that recognize beta amyloid peptide
    Publication number: 20040171816
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: November 7, 2003
    Publication date: September 2, 2004
    Inventors: Dale B. Schenk, Guriq Basi
  • Humanized antibodies that recognize beta amyloid peptide
    Publication number: 20040171815
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Preferred agents include humanized antibodies.
    Type: Application
    Filed: November 7, 2003
    Publication date: September 2, 2004
    Inventors: Dale B. Schenk, Ted Yednock, Guriq Basi
  • PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
    Publication number: 20040170641
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: September 2, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040166119
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: August 26, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040157779
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: March 31, 2004
    Publication date: August 12, 2004
    Applicant: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of synucleinopathic disease
    Publication number: 20040146521
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.
    Type: Application
    Filed: October 31, 2003
    Publication date: July 29, 2004
    Inventors: Dale B. Schenk, Eliezer Masliah
  • Prevention and treatment of synucleinopathic disease
    Publication number: 20040136993
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.
    Type: Application
    Filed: October 31, 2003
    Publication date: July 15, 2004
    Inventors: Dale B. Schenk, Eliezer Masliah
  • Passive immunization treatment of Alzheimer's disease
    Patent number: 6761888
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: July 13, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Humanized and chimeric N-terminal amyloid beta-antibodies
    Patent number: 6750324
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: June 15, 2004
    Assignee: Neuralab Limited
    Inventors: Dale B. Schenk, Frederique Bard, Theodore Yednock
  • Prevention and treatment of amyloidogenic disease
    Patent number: 6743427
    Abstract: The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A&bgr; in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A&bgr; and antibodies binding to the same.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: June 1, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040081657
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: May 2, 2003
    Publication date: April 29, 2004
    Applicants: Neuralab Limited, Athena Neurosciences, Inc.
    Inventor: Dale B. Schenk